Sam Chun Dang Pharm. Co. Ltd (000250) - Total Liabilities

Latest as of September 2025: ₩174.97 Billion KRW ≈ $118.57 Million USD

Based on the latest financial reports, Sam Chun Dang Pharm. Co. Ltd (000250) has total liabilities worth ₩174.97 Billion KRW (≈ $118.57 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Sam Chun Dang Pharm. Co. Ltd - Total Liabilities Trend (2012–2024)

This chart illustrates how Sam Chun Dang Pharm. Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See Sam Chun Dang Pharm. Co. Ltd (000250) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Sam Chun Dang Pharm. Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Sam Chun Dang Pharm. Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Indorama Ventures PCL BK:IVL	Thailand	฿394.53 Billion
Munters Group AB ST:MTRS	Sweden	Skr15.16 Billion
Beijing Shougang Co Ltd SHE:000959	China	CN¥74.10 Billion
IONOS GROUP N XETRA:IOS	Germany	€1.38 Billion
Shenzhen Woer Heat-Shrinkable Material Co Ltd SHE:002130	China	CN¥5.29 Billion
Chenzhou Jingui Silver Industry Co Ltd SHE:002716	China	CN¥3.35 Billion
Proya Cosmetics Co Ltd Class A SHG:603605	China	CN¥2.80 Billion
Bestechnic (Shanghai) Co. Ltd. A SHG:688608	China	CN¥568.95 Million

Liability Composition Analysis (2012–2024)

This chart breaks down Sam Chun Dang Pharm. Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Sam Chun Dang Pharm. Co. Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.48	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.65	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.33	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sam Chun Dang Pharm. Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sam Chun Dang Pharm. Co. Ltd (2012–2024)

The table below shows the annual total liabilities of Sam Chun Dang Pharm. Co. Ltd from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩253.67 Billion ≈ $171.91 Million	+131.53%
2023-12-31	₩109.56 Billion ≈ $74.25 Million	-44.96%
2022-12-31	₩199.05 Billion ≈ $134.89 Million	+15.79%
2021-12-31	₩171.90 Billion ≈ $116.50 Million	+31.77%
2020-12-31	₩130.45 Billion ≈ $88.41 Million	-1.38%
2019-12-31	₩132.28 Billion ≈ $89.64 Million	+17.43%
2018-12-31	₩112.64 Billion ≈ $76.33 Million	+26.84%
2017-12-31	₩88.80 Billion ≈ $60.18 Million	+11.08%
2016-12-31	₩79.95 Billion ≈ $54.18 Million	+14.30%
2015-12-31	₩69.94 Billion ≈ $47.40 Million	+113.15%
2014-12-31	₩32.81 Billion ≈ $22.24 Million	-9.22%
2013-12-31	₩36.15 Billion ≈ $24.50 Million	+1.98%
2012-12-31	₩35.44 Billion ≈ $24.02 Million	--

About Sam Chun Dang Pharm. Co. Ltd

KQ:000250 Korea Pharmaceuticals

Market Cap

$3.84 Billion

₩5.67 Trillion KRW

Market Cap Rank

#4310 Global

#108 in Korea

Share Price

₩265000.00

Change (1 day)

-0.38%

52-Week Range

₩144400.00 - ₩1000000.00

All Time High

₩1000000.00